Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -28.87 is 220% below its 5-year average of -9.01, near the low end of its 5-year range (-34.67–0.38).
67.46% below its 12-month average of -17.24.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.36.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:42:32.122Z. Historical observations retain their original dates. Historical series through 2025-11-05.
EARNINGS PER SHARE (EPS)
-28.87
EARNINGS PER SHARE (EPS) AVG TTM
-17.24
EARNINGS PER SHARE (EPS) AVG 3Y
-11.28
EARNINGS PER SHARE (EPS) AVG 5Y
-9.01
EARNINGS PER SHARE (EPS) AVG 10Y
-9.36
EARNINGS PER SHARE (EPS) AVG 15Y
-5.46
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-67.46%
CURRENT VS 3Y AVG
-156.05%
CURRENT VS 5Y AVG
-220.36%
CURRENT VS 10Y AVG
-208.32%
CURRENT VS 15Y AVG
-429.05%
CURRENT VS 20Y AVG
N/A
Minerva Neurosciences, Inc.
Market Cap
$159.80M
Earnings Per Share (EPS)
-28.87
TTM Avg
-17.24
3Y Avg
-11.28
5Y Avg
-9.01
Market Cap
$159.71M
Earnings Per Share (EPS)
-1.50
TTM Avg
-2.49
3Y Avg
-3.17
5Y Avg
-2.41
Market Cap
$163.00M
Earnings Per Share (EPS)
-1.02
TTM Avg
-0.60
3Y Avg
-1.87
5Y Avg
-1.57
Market Cap
$157.01M
Earnings Per Share (EPS)
-0.90
TTM Avg
-1.19
3Y Avg
-2.61
5Y Avg
-1.83
Market Cap
$163.27M
Earnings Per Share (EPS)
-2.63
TTM Avg
-1.75
3Y Avg
-1.74
5Y Avg
-1.61
Market Cap
$165.51M
Earnings Per Share (EPS)
0.23
TTM Avg
-0.41
3Y Avg
-0.62
5Y Avg
-0.44
Market Cap
$154.79M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.38
3Y Avg
-0.76
5Y Avg
-1.59
Market Cap
$154.14M
Earnings Per Share (EPS)
-0.43
TTM Avg
-0.98
3Y Avg
-1.10
5Y Avg
-1.18
Market Cap
$166.70M
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.50
3Y Avg
-2.00
5Y Avg
-2.13
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $159.80M | -28.87 | -17.24 | -11.28 | -9.01 |
| PepGen Inc. (PEPG)vs › | $159.71M | -1.50 | -2.49 | -3.17 | -2.41 |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -1.02 | -0.60 | -1.87 | -1.57 |
| Inogen, Inc. (INGN)vs › | $157.01M | -0.90 | -1.19 | -2.61 | -1.83 |
| Quanterix Corporation (QTRX)vs › | $163.27M | -2.63 | -1.75 | -1.74 | -1.61 |
| OptimizeRx Corp. (OPRX)vs › | $165.51M | 0.23 | -0.41 | -0.62 | -0.44 |
| LifeMD, Inc. (LFMDP)vs › | $154.79M | -0.51 | -0.38 | -0.76 | -1.59 |
| Neuronetics, Inc. (STIM)vs › | $154.14M | -0.43 | -0.98 | -1.10 | -1.18 |
| Nkarta, Inc. (NKTX)vs › | $166.70M | -1.57 | -1.50 | -2.00 | -2.13 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | N/A | -0.05 | -0.06 | -0.06 |
Trailing EPS (TTM)
$-28.87
Forward EPS (Est.)
$-2.52
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -34.67 |
| 2024-12-31 | 0.19 |
| 2023-12-31 | -4.61 |
| 2022-12-31 | -6.01 |
| 2021-12-31 | -9.35 |
| 2020-12-31 | 0.38 |
| 2019-12-31 | -14.80 |
| 2018-12-31 | -10.35 |
| 2017-12-31 | -6.65 |
| 2016-12-31 | -7.88 |
| 2015-12-31 | -9.25 |
| 2014-12-31 | -25.11 |
| 2013-12-31 | -1.43 |
| 2012-12-31 | -0.69 |
| 2011-12-31 | -0.49 |
